Co-infection and Cancer (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-056 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infection-related cancers. Co-infection is defined as the occurrence of infections by two or more infectious (pathogenic or non-pathogenic) agents either concurrently or sequentially and includes both acute and chronic infections by viruses, bacteria, parasites...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2022 Category: Research Source Type: funding
Co-infection and Cancer (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-055 from the NIH Guide for Grants and Contracts. This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to co-infections (excluding co-infection with human immunodeficiency virus [HIV]) that engendered novel opportunities for prevention and treatment and focus on understudied populations. Coinfection is defined as the occurrence of infections by two or more infectious (pathogenic or nonpathogenic) agents either concurrently or sequentially and includes...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2022 Category: Research Source Type: funding
Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-21-075 from the NIH Guide for Grants and Contracts. To expand our understanding of protozoan parasite persistence mechanisms and provide research tools and strategies to enable identification and credentialing of novel treatments for persistent protozoan pathogens. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 18, 2021 Category: Research Source Type: funding
Co-infection and Cancer (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-061 from the NIH Guide for Grants and Contracts. This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to investigations of co-infections with known oncogenic agents (e.g., Helicobacter pylori [H. pylori] and Epstein Barr virus [EBV]; excluding human immunodeficiency virus [HIV]) and of co-infections that engendered novel opportunities for prevention and treatment. Coinfection is defined as the occurrence of infections by two or more infectious (patho...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2019 Category: Research Source Type: funding
Co-infection and Cancer (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-062 from the NIH Guide for Grants and Contracts. This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to investigations of co-infections with known oncogenic agents (e.g., Helicobacter pylori [H. pylori] and Epstein Barr virus [EBV]; excluding human immunodeficiency virus [HIV]) and of co-infections that engendered novel opportunities for prevention and treatment. Coinfection is defined as the occurrence of infections by two or more infectious (patho...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2019 Category: Research Source Type: funding
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-059 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to stimulate basic research, discovery, and early translational research to enable and accelerate the generation of highly efficacious pre-erythrocytic stage, sporozoite-based vaccines. Cross-fertilization and collaboration among investigators from malaria vaccine research and other basic research areas such as parasite biology, parasite genomics, pathogenesis, and host immunology are highly encouraged. The goal is to generate one or more promising vaccine candidates against human malaria that exhibit perform...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 11, 2019 Category: Research Source Type: funding
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. This opportunity is specifically designed to promote partnerships between eligible NIH Intramural Research Program (IRP) investigators (e.g. those conducting research within the labor...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
Funding Opportunity PA-19-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 26, 2018 Category: Research Source Type: funding
Plant Biotic Interactions
Funding Opportunity ID: 292447 Opportunity Number: 16-551 Opportunity Title: Plant Biotic InteractionsOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 10.31047.074Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: *Who May Submit Proposals: Proposals may only be submitted by the following:
-Non-profit, non-academic organizations: Ind...
Source: Grants.gov - March 14, 2017 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Plant Biotic Interactions
Funding Opportunity ID: 282034 Opportunity Number: 16-551 Opportunity Title: Plant Biotic InteractionsOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 10.31047.074Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: *Who May Submit Proposals: Proposals may only be submitted by the following:
-Non-profit, non-academic organizations: Ind...
Source: Grants.gov - February 23, 2017 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Nano-Biosensing
Funding Opportunity ID: 291986 Opportunity Number: PD-17-7909 Opportunity Title: Nano-BiosensingOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 47.041Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Additional Information on Eligibility: Agency Code: NSFAgency Name: National Science FoundationPosted Date: Feb 2...
Source: Grants.gov - February 22, 2017 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Determining and Monitoring Health Conditions Identified in the Medical Assessment of US-Bound Refugees
Funding Opportunity ID: 289713 Opportunity Number: RFA-CK-17-004 Opportunity Title: Determining and Monitoring Health Conditions Identified in the Medical Assessment of US-Bound RefugeesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.084Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Single Source Competition - International Organization for Migration (IOM)Agenc...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
“Reducing the Burden of Neglected Parasitic Infections (NPIs) in the United States through Evidence-Based Prevention and Control Activities”
Funding Opportunity ID: 291683 Opportunity Number: CDC-RFA-GH15-161703CONT17 Opportunity Title: “Reducing the Burden of Neglected Parasitic Infections (NPIs) in the United States through Evidence-Based Prevention and Control Activities”Opportunity Category: ContinuationOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.084Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: This award will be a conti...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
